To investigate the possible involvement of some cell surface structures on lymphoid cells in the functional activity of lymphokine activated killer (LAK) cells, a number of monoclonal antibodies (Mab) against such structures was studied for their ability to inhibit LAK activity in a standard cytotoxicity assay against the natural killer-insensitive target cell EL-4. Almost complete inhibition of LAK activity resulted from incubation with antibodies to the LFA-1 antigen, while blocking of the Lyt 2 antigen reduced cytotoxic activity about 50%. Mab to T-200 gave a weak and inconsistent inhibitory activity, while antibodies to Thy 1, L3T4, IL-2 receptor and MHC class I antigens were without effect. Mab to LFA-1 and Lyt 2 inhibited LAK activity...
Lymphokine-activated killer (LAK) activity was first analyzed on PBL populations fractionated on the...
We evaluated the effect of the antibodies to adhesion molecules CD2, CD11a/CD18 (LFA-1), and CD56 (N...
The role of major histocompatibility gene products (i.e., HLA molecules) in rendering tumor cells re...
Lymphokine-activated killer (LAK) cells were generated from peripheral blood lymphocytes (PBL) that ...
Our main objective was to determine if the Lymphokine Activated Killer cells (LAK) activity is restr...
Thymocytes were removed from mice at different times before and after birth, and their phenotype and...
Lymphokine (i.e., interleukln 2; IL-2)-activated killer (LAK) cells derived from normal hu-man blood...
Lymphokine activated killer (LAK) cells are generated by a culture of lymphocytes with interleukin 2...
Lymphokine-activated killer (LAK) cells can be generated by incubating peripheral blood lymphocytes ...
We have analyzed interleukin-2 stimulated killer activity derived from peripheral blood lymphocytes ...
Recently we described a new monoclonal antibody, termed LAK1, which recognizes a 120-kDa surface ant...
Human peripheral blood lymphocytes (PBL) cultured for varying lengths of time in IL-2 are able to me...
True antigen receptors on murine natural killer (NK) cells have not been identified. In this study, ...
Lymphokine-activated killer (LAK) cells generated by cultivation of C57BL/6 mouse spleen cells in th...
Human peripheral blood lymphocytes (PBL) cultured for varying lengths of time in IL-2 are able to me...
Lymphokine-activated killer (LAK) activity was first analyzed on PBL populations fractionated on the...
We evaluated the effect of the antibodies to adhesion molecules CD2, CD11a/CD18 (LFA-1), and CD56 (N...
The role of major histocompatibility gene products (i.e., HLA molecules) in rendering tumor cells re...
Lymphokine-activated killer (LAK) cells were generated from peripheral blood lymphocytes (PBL) that ...
Our main objective was to determine if the Lymphokine Activated Killer cells (LAK) activity is restr...
Thymocytes were removed from mice at different times before and after birth, and their phenotype and...
Lymphokine (i.e., interleukln 2; IL-2)-activated killer (LAK) cells derived from normal hu-man blood...
Lymphokine activated killer (LAK) cells are generated by a culture of lymphocytes with interleukin 2...
Lymphokine-activated killer (LAK) cells can be generated by incubating peripheral blood lymphocytes ...
We have analyzed interleukin-2 stimulated killer activity derived from peripheral blood lymphocytes ...
Recently we described a new monoclonal antibody, termed LAK1, which recognizes a 120-kDa surface ant...
Human peripheral blood lymphocytes (PBL) cultured for varying lengths of time in IL-2 are able to me...
True antigen receptors on murine natural killer (NK) cells have not been identified. In this study, ...
Lymphokine-activated killer (LAK) cells generated by cultivation of C57BL/6 mouse spleen cells in th...
Human peripheral blood lymphocytes (PBL) cultured for varying lengths of time in IL-2 are able to me...
Lymphokine-activated killer (LAK) activity was first analyzed on PBL populations fractionated on the...
We evaluated the effect of the antibodies to adhesion molecules CD2, CD11a/CD18 (LFA-1), and CD56 (N...
The role of major histocompatibility gene products (i.e., HLA molecules) in rendering tumor cells re...